Growing number of successful clinical trials is creating demand for biological pharmaceuticals and prompting various companies to invest in research and development to create biosimilars is driving market growth. Thus, the growing demand for such products is expected to favor the global immunology market growth during the forecast period. For instance, Sandoz Canada launched Hyrimoz, an adalimumab (HUMIRA) biosimilar, in February 2021; the medicine has been approved and is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, adult Crohn’s disease, and adult uveitis, among others.
The global immunology market is estimated to be valued at $ 91,850 Million in 2021 and is expected to reach $ 156,378.2 million by 2028, at a CAGR of 8% during the forecast period (2022–2028).
“We do have a sample of this report available. Please read the following information to gain access to the report.”
– Brief Introduction to the research report.
– Table of Contents (Scope covered as a part of the study)
– Top players in the market
– Research framework (structure of the report)
– Research methodology adopted by Coherent Market Insights
Request Here For The Sample Copy Of The Report @
COVID-19 pandemic has affected various industries globally. The players operating in the global Immunology market are facing major challenges on various fronts due to the COVID-19 pandemic. COVID-19 disease has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Although for majority of market players the COVID-19 outbreak had a minimal impact on sales generated by immunological drugs; owing to an improved supply chain management, enhanced R&D capability, and an increased investment in manufacturing management & quality control. For instance in 2020, AbbVie Inc. reported an increase of 13.2% in the sales generated from the drugs as compared to in 2019. However, because to the COVID-19 pandemic, a few market participants saw a drop in revenues from immunology-related medications.
Growing acquisitions and collaboration among key players is propelling the growth of the global immunology market. For instance, Momenta Pharmaceuticals, Inc., a firm that discovers innovative medicines for immune-mediated disease, was acquired by Johnson & Johnson in August 2020. The Janssen Pharmaceutical Companies of Johnson & Johnson will be able to broaden their leadership in immune-mediated diseases and accelerate growth by expanding into autoantibody-driven disease as a result of this acquisition.
The global immunology market is expected to exhibit a CAGR of 8% during the forecast period, owing to the growing prevalence of autoimmune conditions. According to the British Society for Immunology, an estimated 400,000 persons in the United Kingdom had rheumatoid arthritis in 2018, and an estimated 4 million people had an autoimmune disease.
Among drug class, Monoclonal Antibody (mAb) segment is expected to dominate the immunology market due to the established clinical efficiency of monoclonal antibodies such as adalimumab, rituximab, and the treatment of rare and chronic conditions as well as autoimmune diseases. For instance, STELARA (Ustekinumab), a human IgG1k monoclonal antibody developed by Janssen Global Services, LLC, was authorised by the US FDA in July 2020 to treat children patients with moderate to severe plaque psoriasis.
Request PDF Brochure with Latest Insights @
Major players operating in the global Immunology market include AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.
Reasons to buy this Immunology Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Immunology Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Immunology Market
◘ Leading company profiles reveal details of key Immunology Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Immunology Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Immunology Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Immunology Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immunology Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Immunology Industry Impact
Chapter 2 Global Immunology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immunology (Volume and Value) by Type
2.3 Global Immunology (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Immunology Sales, Consumption, Export, Import by Regions
Chapter 5 North America Immunology Market Analysis
Chapter 6 East Asia Immunology Market Analysis
Chapter 7 Europe Immunology Market Analysis
Chapter 8 South Asia Immunology Market Analysis
Chapter 9 Southeast Asia Immunology Market Analysis
Chapter 10 Middle East Immunology Market Analysis
Chapter 11 Africa Immunology Market Analysis
Chapter 12 Oceania Immunology Market Analysis
Chapter 13 South America Immunology Market Analysis
Chapter 14 Company Profiles and Key Figures in Immunology Business
Chapter 15 Global Immunology Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027